A swiss-based company developing therapeutics for chronic inflammation.
We are engineering novel bi-functional Duokine therapeutics, rationally designed to simultaneously target distinct immune cell populations and disease-relevant pathways.
A swiss-based company developing therapeutics for chronic inflammation.
We are engineering novel bi-functional Duokine therapeutics, rationally designed to simultaneously target distinct immune cell populations and disease-relevant pathways.
Route de la Corniche 15, 1010 Épalinges, Switzerland